John M. Evans
CIK 1786304 · CEO · last filed 2026-10-16
John M. Evans is a CEO who has filed 51 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for BEAM, was dated Oct 16, 2026. Across all open-market trades the lifetime net is −$39.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $28.4M across reported positions. 48 SEC filings were submitted jointly with Beam Therapeutics Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BEAM price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
26 LANDSDOWNE STREET
CAMBRIDGE, MA 02139
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BEAM | CEO | 1,175,205 | $24.18 | $28.42M | -$39.82M | 32 | 2026-10-16 |
| Verve Therapeutics, Inc. (VERV) Delisted | Director | — | $11.13 | — | $0 | 1 | 2022-06-13 |
Recent Filings
51 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-10-16 | BEAM | Notice (144) | −25,000 | -$599.6K | EDGAR |
| 2026-10-16 | BEAM | Mixed | — | -$1.14M | EDGAR |
| 2026-10-15 | BEAM | Notice (144) | −25,000 | -$589.1K | EDGAR |
| 2026-07-01 | BEAM | Mixed | — | -$1.70M | EDGAR |
| 2026-06-30 | BEAM | Notice (144) | −25,000 | -$857.7K | EDGAR |
| 2026-06-29 | BEAM | Notice (144) | −25,000 | -$887.4K | EDGAR |
| 2026-04-06 | BEAM | Sell (S) | −30,078 | -$739.3K | EDGAR |
| 2026-04-01 | BEAM | Mixed | +90,000 | -$1.09M | EDGAR |
| 2026-03-31 | BEAM | Notice (144) | −25,000 | -$569.1K | EDGAR |
| 2026-03-31 | BEAM | Notice (144) | −66,874 | -$1.46M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.